(a) whether according to WHO, India has adopted wrong treatment of malaria policy in the country;
(b) if so,the details thereof and the reaction of the Union government thereto;
(c) the corrective measures taken by the Union Government in view of the above revelation;and
(d) the details of strategy adopted by the Union Government to check the spread of malaria in the
country?
THE MINISTER OF STATE IN THE MINISTRY OF HEALTH & FAMILY WELFARE(SMT. PANABAKA LAKSHMI)
(a) to (c): No,Sir.National Vector Borne Disease Control Programme (NVBDCP),Government of India
is using the WHO recommended malaria treatment policy for treatment of both P.vivax and
P.falciparum.
Under the National Drug Policy on Malaria,treatment of P.vivax cases is with clloroquine 25 mg/kg
body weight divided over three days along with Primaquine in dose of 0.25mg/Kg. bw daily for 14
days.
Chloroquine @ 25 mg/kg body weight divided over three days along with Primaquine single dose of
0.75 mg/kg bw on day 1 are to be given for pf cases.
In chloroquine resistant areas Artesunate Combination Therapy (ACT) i.e. artesunate plus sulfa
pyrimethamine is to be given to treat the confirm Pf cases. At present such regimen is being used
in 117 most Pf endemic districts and another 253 Public Health Centres (PHCs) having chloroquine
resistance and surrounding cluster of block in the country.
(d) For effective control of malaria, under NVBDCP, the revised malaria control strategy includes,
inter alia, the following:
# Use of Rapid Diagnostic Kits for the Pf case diagnosis in the remote and inaccessible areas
having no microscopy centre.
# Use of ACT for treating confirmed Pf cases in all high Pf predominant areas.
# Use of impregnated bed nets for Vector control in high transmission areas with operational
difficulties in carrying out Indoor Residual Spray.